Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study

BACKGROUND: Patients with intermediate to advanced hepatocellular carcinoma (HCC) are most commonly treated with transarterial chemoembolization (TACE). Previous studies showed that TACE combined with recombinant human adenovirus type 5 (H101) may provide a clinical survival benefit. In the present...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chin J Cancer
Asıl Yazarlar: He, Chao-Bin, Lao, Xiang-Ming, Lin, Xiao-Jun
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518415/
https://ncbi.nlm.nih.gov/pubmed/28728568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40880-017-0227-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller